Macrolide Resistance Trends in β-Hemolytic Streptococci in a Tertiary Korean Hospital
1
조회
0
다운로드
8
인용
0
참고문헌
초록
Abstract
Purpose: Erythromycin-resistant β-hemolytic streptococci (BHS) has recently emerged and quickly spread between and within countries throughout the world. In this study, we evaluate the antimicrobial susceptibility patterns and erythromycin resistance mechanisms of BHS during 2003-2004. Materials and Methods: The MICs of seven antimicrobials were determined for 204 clinical isolates of BHS from 2003 to 2004. Resistance mechanisms of erythromycin-resistant BHS were studied by the double disk test as well as by polymerase chain reaction (PCR). Results: Compared with our previous study, resistance among Streptococcus pyogenes isolates to a variety of drugs decreased strikingly: from 25.7% to 4.8% in erythromycin; 15.8% to 0% in clindamycin; and 47.1% to 19.0% in tetracycline. The prevalent phenotypes and genotypes of macrolide-lincosamide- streptograminB (MLSB) resistance in Streptococcus pyogenes isolates have been changed from the constitutive MLSB phenotype carrying erm(B) to the M phenotype with mef(A) gene. In contrast with Streptococcus pyogenes, resistance rates to erythromycin (36.7%), clindamycin (43.1%), and tetracycline (95.4%) in Streptococcus agalactiae isolates did not show decreasing trends. Among the Streptococcus dysgalactiae subsp. equisimilis isolates (Lancefield group C, G), resistance rates to erythromycin, clindamycin, tetracycline and chloramphenicol were observed to be 9.4%, 3.1%, 68.8%, and 9.4%, respectively. Conclusion: Continual monitoring of antimicrobial resistance among large-colony-forming BHS is needed to provide the medical community with current data regarding the resistance mechanisms that are most common to their local or regional environments.
참고문헌 (22)
- Ruoff KL, "Streptococcus", pp.405~421 (2003), Washington DC: American Society for Microbiology
- Bisno AL, "Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis", 35, pp.113~125 (2002)
- Schuchat A, "Group B streptococcal disease: from trials and tribulations to triumph and trepidation", 33, pp.751~756 (2001)
- Biedenbach DJ, "Antimicrobial susceptibility profile among β-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program-North America, 2001", 46, pp.291~294 (2003)
- Carroll KC, "Susceptibility of β-hemolytic streptococci to nine antimicrobial agents among four medical centers in Salt Lake City, Utah, USA", 27, pp.123~128 (1997)
- Gordon KA, "Antimicrobial susceptibility patterns of β-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000)", 43, pp.157~162 (2002)
- Traub WH, "Comparative susceptibility of clinical group A, B, C, F, and G β-hemolytic streptococcal isolates to 24 antimicrobial drugs", 43, pp.10~20 (1997)
- Wu JJ, "High incidence of erythromycin-resistant streptococci in Taiwan", 41, pp.844~846 (1997)
- Avanzini C, "Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998: survey of macrolide resistance and trend of genotype by RAPD", 6, pp.289~295 (2000)
- Kataja J, "Clonal relationships among isolates of erythromycin-resistant Streptococcus pyogenes of different geographical origin", 21, pp.589~595 (2002)
- Seppl H, "The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland", 337, pp.441~446 (1997)
- Chong Y, "Present situation of antimicrobial resistance in Korea", 6, pp.189~195 (2000)
- Kim HY, "Macrolide resistance in β-hemolytic streptococci: changes after the implementation of the separation of prescribing and dispensing of medications policy in Korea", 45, pp.591~597 (2004)
- Uh Y, "Antimicrobial susceptibility patterns and macrolide resistance genes of β-hemolytic streptococci in Korea", 48, pp.2716~2718 (2004)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. CLSI document M100-S16" (2006), Wayne (PA): Clinical and Laboratory Standards Institute
- Uh Y, "Serogroup distribution of beta-hemolytic streptococci isolated from a tertiary care hospital at Wonju area during the recent 4 years (1997-2000)", 33, pp.173~180 (2001)
- Uh Y, "Emergence of erythromycin-resistant Streptococcus agalactiae serotype V is due to clonal spread", 25, pp.S564~ (2005)
- Ko WC, "Serotyping and antimicrobial susceptibility of group B Streptococcus over an eight-year period in southern Taiwan", 20, pp.334~339 (2001)
- .Malbruny B, "A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand", 54, pp.1040~1044 (2004)
- Woo PC, "Group G beta-hemolytic streptococcal bacteremia characterized by 16S ribosomal RNA gene sequencing", 39, pp.3147~3155 (2001)
- Zaoutis T, "Antibiotic susceptibilities of group C and group G streptococci isolated from patients with invasive infections: evidence of vancomycin tolerance among group G serotypes", 37, pp.3380~3383
- Hashikawa S, "Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome", 42, pp.186~192 (2004)